Loading...
Market
What changes in leadership will occur at Triomics by the end of 2025?
3
Resolution / Starting Odds
No change • 33%
New CEO • 33%
Change in other top management • 34%
Company press releases and major business news outlets
Story
Triomics Raises $15M Series A, Led by k__sarim and hrituraj1997, for AI Cancer Care
May 9, 2024, 05:06 PM
Triomics, a US-based startup, has successfully raised $15 million in a Series A funding round to enhance oncology workflows through the automation of cancer clinical trials matching using Generative AI. The funding round saw participation from prominent investors including Y Combinator, Lightspeed Venture Partners, General Catalyst, and Nexus Venture Partners. This AI-driven platform is set to revolutionize healthcare by improving the analysis of medical data, aiding drug discovery, clinical trials, and care delivery, ultimately benefiting doctors and patients alike. The team, led by k__sarim and hrituraj1997, is at the forefront of this transformative technology.
View original story
Similar markets
No change • 25%
New CEO appointed • 25%
Major board reshuffle • 25%
Leadership remains but restructured • 25%
CEO change • 33%
CFO change • 33%
No significant leadership change • 34%
Yes • 50%
No • 50%
Successor announced • 33%
No changes • 33%
Major leadership restructuring • 34%
No change in leadership • 34%
CEO replaced • 33%
CFO replaced • 33%
CEO replaced • 25%
CFO replaced • 25%
No major leadership change • 25%
Other C-level executive replaced • 25%
No change in leadership • 25%
CEO replaced • 25%
Board members replaced • 25%
Other executive changes • 25%
No change • 33%
New director appointed • 33%
Major reshuffling of senior positions • 33%
No change • 33%
Change in CEO • 33%
Change in Senior Management • 34%